DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
| User | Tweets |
|---|---|
| @Tickeron | 14 |
| @VisualStockRSRC | 7 |
| @AmericanBanking | 6 |
| @1MinuteStock | 5 |
| @TheMarketsDaily | 4 |
Recent Tweets for CYTK
 |
@Tickeron $CYTK in Downtrend: Stochastic indicator stays in oversold zone for 7 days. View odds for this and other indicators… https://t.co/NdlI9ZuIHQ 12:11am |
 |
@AlertTrade TREND REVERSAL UP ALERT: $CYTK Cytokinetics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room November 15th 2019, 2:11pm |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator remains in oversold zone for 6 days. View odds for this and other indicato… https://t.co/XoZvgBxdBy November 14th 2019, 11:11pm |
 |
@tradersreport RT @Tickeron: $CYTK in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on November 7, 2019. View odds for t… November 13th 2019, 11:11pm |
|
@Tickeron $CYTK in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on November 7, 2019. View… https://t.co/LpI20GLJaI November 13th 2019, 11:11pm |
 |
@TradeFlags TD BUY $CYTK at 8.10, Supp 7.95 Resis 11.84 R49 HiLo 26% T1Y 22 buy 2.2 fwdPE -4.0 DIV N/A #Cytokineti #stocks… https://t.co/bIyzbZmStP November 13th 2019, 8:11pm |
 |
@fintel_io $CYTK / Cytokinetics files form 8-K - Entry into a Material Definitive Agreement, Financial Statements and Exhibits… https://t.co/kXhy7ep1r7 November 13th 2019, 5:11pm |
|
@AlertTrade MOST ACTIVE ALERT: $CYTK Cytokinetics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room November 13th 2019, 11:11am |
 |
@TheMarketsDaily $7.19 Million in Sales Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/21pd9mwRDA November 12th 2019, 11:11pm |
 |
@stocknewstimes $7.19 Million in Sales Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/ycjJ814OPI November 12th 2019, 11:11pm |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator stays in oversold zone for 4 days. View odds for this and other indicators… https://t.co/v94BSyllQb November 12th 2019, 11:11pm |
 |
@Gambiste1 RT @HCWCO: #HCWCO acted as a co-manager for $CYTK on a $120 million #convertiblenote transaction. View all of our recent transactions here… November 12th 2019, 12:11pm |
 |
@HCWCO #HCWCO acted as a co-manager for $CYTK on a $120 million #convertiblenote transaction. View all of our recent trans… https://t.co/z5ZlyEKbjA November 12th 2019, 9:11am |
|
@stocknewstimes Cytokinetics $CYTK Stock Rating Lowered by BidaskClub https://t.co/CbpHLleqwD November 12th 2019, 4:11am |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator stays in oversold zone for 3 days. View odds for this and other indicators… https://t.co/hCcJgBv6wI November 11th 2019, 10:11pm |
 |
@TickerReport Cytokinetics $CYTK Rating Lowered to Sell at BidaskClub https://t.co/RfLX2rjmjI November 11th 2019, 9:11pm |
 |
@otcdynamics $CYTK Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart Association https://t.co/J4GRPrK7Ek November 11th 2019, 9:11am |
 |
@1MinuteStock We calculated 63-day Expected Return of $CYTK for you: -34.39% https://t.co/ANdISJBylL November 11th 2019, 9:11am |
 |
@VisualStockRSRC $CYTK - Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart https://t.co/lyRFusgNu4 November 11th 2019, 9:11am |
 |
@MC_OptionTrades $CYTK 15-Nov-19 Straddle Implies a ±5.9% move. Nov 12 Credit Suisse 28th Annual Healthcare Conference https://t.co/RAQCvG1R6t November 11th 2019, 8:11am |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator sits in oversold zone for 3 days. View odds for this and other indicators:… https://t.co/WT28eBvYK3 November 10th 2019, 11:11pm |
 |
@IlliniJJ $CYTK nasty sell off good entry opportunity, upcoming catalysts: Phase 1 Ascending Dose Study of CK-3773274 in Hea… https://t.co/46DUjLUvDp November 10th 2019, 4:11pm |
 |
@dakotafinancial Cytokinetics, Inc. $CYTK Expected to Announce Earnings of -$0.51 Per Share https://t.co/kBoClQBVwg November 10th 2019, 2:11pm |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $CYTK is $-0.7 it's -8.54% of the current price https://t.co/NFI63TP3Sf November 10th 2019, 12:11pm |
 |
@SeasonalEdge Today's insight on $CYTK https://t.co/VWXEt1dahC https://t.co/0a5D4kh9EB November 10th 2019, 11:11am |
 |
@1stOncology #Cytokinetics Announces Pricing of #PublicOffering of Convertible Senior Notes $CYTK https://t.co/1fPhDfrllg November 10th 2019, 10:11am |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator stays in oversold zone for 3 days. View odds for this and other indicators… https://t.co/qdT84RELAU November 10th 2019, 1:11am |
|
@1MinuteStock Unicorn Bay rating for $CYTK is 2.37 out of 5. https://t.co/0ZFzvIX2Z3 November 9th 2019, 1:11pm |
|
@1MinuteStock Recommendation #HOLD for $CYTK with UB rating - 2.37 out of 5. https://t.co/EwdsbFcN4C November 9th 2019, 1:11pm |
 |
@MarketChmln $CYTK option volume was 22X normal on Friday with 3,618 contracts. Call volume was 83% and put volume was 17%. https://t.co/8ORCza1Koa November 9th 2019, 9:11am |
 |
@ConsumerFeed Cytokinetics $CYTK Stock Rating Lowered by BidaskClub https://t.co/Rot204f7sF November 9th 2019, 7:11am |
 |
@bbnsnews Cytokinetics $CYTK Stock Rating Lowered by BidaskClub https://t.co/sl2NDQxZgR November 9th 2019, 7:11am |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator is remaining in oversold zone for 2 days. View odds for this and other ind… https://t.co/b1Y7UxO0Ii November 9th 2019, 4:11am |
 |
@AmericanBanking $7.19 Million in Sales Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/g5EDv4mhCz #stocks November 9th 2019, 2:11am |
|
@TickerReport $7.19 Million in Sales Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/qYXPEoS6D6 November 9th 2019, 2:11am |
 |
@dailypoliticaln $7.19 Million in Sales Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/57sRYivMEV November 9th 2019, 2:11am |
|
@bbnsnews Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/Cbqwzb1jkH November 9th 2019, 12:11am |
 |
@BlueBioNow $CYTK $8.73+ by soon?.. -3.99 % change recently https://t.co/1UwivKNajm November 8th 2019, 11:11pm |
|
@fintel_io Insider Malik Fady Ibraham reports selling 1,500 shares of $CYTK for a total cost of $14,970.00 [CLICK FOR PREDIC… https://t.co/buLzxGwczy November 8th 2019, 10:11pm |
|
@SeasonalEdge Today's insight on $CYTK https://t.co/VWXEt1dahC https://t.co/LuZ9Mozb6U November 8th 2019, 9:11pm |
|
@AmericanBanking Insider Selling: Cytokinetics, Inc. $CYTK EVP Sells 1,500 Shares of Stock https://t.co/bFMM08Q4p5 #stocks November 8th 2019, 7:11pm |
|
@TheMarketsDaily Insider Selling: Cytokinetics, Inc. $CYTK EVP Sells 1,500 Shares of Stock https://t.co/B11AdqVjP4 November 8th 2019, 7:11pm |
|
@AmericanBanking Cytokinetics, Inc. $CYTK Receives Average Rating of “Buy” from Brokerages https://t.co/jDPybhZ1T8 #stocks November 8th 2019, 7:11pm |
 |
@InsiderAlertsIA $CYTK: New Insider Filing on EVP Research & Development FADY IBRAHAM MALIK: https://t.co/U52NwxJGPE November 8th 2019, 5:11pm |
|
@VisualStockRSRC $CYTK - Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) https://t.co/zzT6CV4PLi November 8th 2019, 5:11pm |
 |
@Cytokinetics Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes $CYTK https://t.co/oC7tT2nGQm https://t.co/LAjfKA134d November 8th 2019, 11:11am |
 |
@MarketCurrents $CYTK - Cytokinetics prices convertible debt offering; shares down 4% https://t.co/16kDXaKzoW November 8th 2019, 9:11am |
 |
@Briefingcom $CYTK: Cytokinetics prices offering of $120 mln principal amount of its 4.00% convertible senior notes due 2026 https://t.co/2ILCkLWgIs November 8th 2019, 9:11am |
|
@1MinuteStock Wondering about #sentiment indicator for $CYTK? The Short Ratio is 8.44% https://t.co/zewZCIJde7 November 8th 2019, 7:11am |
 |
@newsfilterio Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes $CYTK https://t.co/gnPsEG9IBd November 8th 2019, 7:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.